Stay updated on Atrasentan in IgA Nephropathy Clinical Trial
Sign up to get notified when there's something new on the Atrasentan in IgA Nephropathy Clinical Trial page.

Latest updates to the Atrasentan in IgA Nephropathy Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe page’s revision tag was updated from v3.5.3 to v3.5.4, indicating a new release of the site framework or content management. This change reflects an internal version update rather than an alteration to the study information or visible user content.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe page’s UI/version label has been updated from “Revision: v3.5.2” to “Revision: v3.5.3” without any accompanying change to the study content.SummaryDifference0.0%

- Check38 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check67 days agoChange DetectedRevision: v3.5.0 added; Revision: v3.4.3 removed.SummaryDifference0.0%

- Check81 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check103 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2; no visible changes to the study details or layout are observed.SummaryDifference0.0%

Stay in the know with updates to Atrasentan in IgA Nephropathy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Atrasentan in IgA Nephropathy Clinical Trial page.